Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -2.225% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) O=C(O)CCCCOn1ccnc1
(b) Cc1ccc(C(=O)/C=C/Nc2ccc3c(c2)OCO3)cc1
(c) COc1ccccc1CNC(=O)C(NS(=O)(=O)c1ccc2c(c1)oc(=O)n2C)C(C)C
Answer: c. COc1ccccc1CNC(=O)C(NS(=O)(=O)c1ccc2c(c1)oc(=O)n2C)C(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccccc1CNC(=O)C(NS(=O)(=O)c1ccc2c(c1)oc(=O)n2C)C(C)C
COc1ccccc1CNC(=O)C(NS(=O)(=O)c1ccc2c(c1)oc(=O)n2C)C(C)C
N-[(2-methoxyphenyl)methyl]-3-methyl-2-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonylamino]butanamide